NCT04518046 2024-06-05Study of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid MalignanciesMirati Therapeutics Inc.Phase 1 Completed22 enrolled
NCT02219711 2023-03-06Phase 1/1b Study of MGCD516 in Patients With Advanced CancerMirati Therapeutics Inc.Phase 1 Completed193 enrolled